2030 年亞太魚疫苗市場預測 - 區域分析 - 按疫苗類型、應用、給藥途徑和物種
市場調查報告書
商品編碼
1481942

2030 年亞太魚疫苗市場預測 - 區域分析 - 按疫苗類型、應用、給藥途徑和物種

Asia Pacific Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species

出版日期: | 出版商: The Insight Partners | 英文 100 Pages | 訂單完成後即時交付

價格

2022年亞太魚苗市場估值為4,687萬美元,預計2030年將達9,415萬美元;預計 2022 年至 2030 年複合年成長率為 9.1%。

新型魚疫苗的開發推動亞太魚疫苗市場的發展

由寄生蟲、病毒和細菌引起的疾病爆發已經減緩了全球水產養殖業數十年的發展。除了危害人類健康外,新出現的疾病也對水生動物產生重大影響。傳統疫苗有其限制和缺點,這增加了對嵌合多表位疫苗等新型先進疫苗開發的需求。科學技術的進步為水產疫苗的基礎和應用研究領域開闢了新的途徑。人們努力利用新技術、新方法、新策略來創造更高品質、更高效率的新型水生疫苗。

利用現有的生物資訊學工具以及免疫蛋白質組學和基因組學的現有知識,研究人員可以識別免疫細胞可以識別的潛在目標表位。此外,隨著全基因組定序等技術的成本持續下降,它為物種特異性疫苗的開發開闢了道路。這可能會增加開發新疫苗的投資。 2021年,中央鹹水水產養殖研究所(ICAR)在印度推出了針對病毒性神經壞死(VNN)的重組疫苗。

因此,開發有效的黏膜疫苗並加強管理流程預計將加速新型疫苗的開發,這將促進地中海國家的水產養殖業規範魚類疫苗接種過程。因此,新型魚類疫苗的開發可能為市場成長創造重大機會。

亞太魚疫苗市場概況

亞太魚疫苗市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。這些國家的市場成長歸功於該地區水產養殖業的崛起和政府的有利措施。此外,市場參與者實施的擴張和產品推出策略預計將有助於該地區魚疫苗市場的成長。自第二次世界大戰結束以來,日本的商業水產養殖生產迅速發展,在漁業部門中佔有重要地位。年度漁業統計的水產養殖部分包括60多個物種。其中,主要品種有海苔、扇貝、牡蠣、鰤、真鯛、海芥等。然而,未來十年國內對海鮮的需求將下降,水產養殖如果繼續依賴國內需求,產量也會下降。日本需求下降是因為日本人口減少,他們的飲食轉向肉類。

亞太魚疫苗市場收入及 2030 年預測(百萬美元)

亞太魚疫苗市場區隔

亞太魚苗市場根據疫苗類型、應用、給藥途徑、物種和國家進行細分。

依疫苗類型,亞太魚苗市場分為去活化疫苗、減毒活疫苗、次單位疫苗、重組載體疫苗等。 2022 年,去活化疫苗細分市場佔據最大市場佔有率。

根據應用,亞太魚苗市場分為細菌感染、病毒感染和寄生蟲。 2022 年,細菌感染細分市場佔最大市場。

根據給藥途徑,亞太魚苗市場分為注射疫苗、浸沒疫苗和口服疫苗。 2022年,注射疫苗細分市場佔據最大市場佔有率。

根據物種,亞太魚苗市場分為鮭魚、鱒魚、羅非魚等。 2022 年,鮭魚細分市場佔據最大的市場。

依國家分類,亞太魚疫苗市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022 年,日本在亞太魚疫苗市場佔有率中佔據主導地位。

崇安疫苗實驗室有限公司; Elanco 動物保健公司;希普拉公司;印度免疫學有限公司; KBNP 公司;京都美研研究所;默克公司;日精研有限公司; Phibro 動物健康公司; Vaxxinova 國際有限公司;和 Zoetis Inc. 是亞太魚疫苗市場上的一些領先公司。

目錄

第 1 章:簡介

第 2 章:執行摘要

  • 亞太魚疫苗市場

第 3 章:研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章:亞太魚疫苗市場 - 主要產業動態

  • 市場促進因素:
    • 政府發展水產養殖業的舉措
    • 水產動物性食品的需求激增
  • 市場限制
    • 疫苗核准的嚴格規定
  • 市場機會
    • 新型魚類疫苗的研發
  • 未來的趨勢
    • 魚類疫苗的技術進步
  • 影響分析:

第 5 章:魚疫苗市場 - 亞太市場分析

  • 魚疫苗市場收入(千美元),2022 - 2030

第 6 章:亞太魚疫苗市場 - 收入和 2030 年預測 - 按疫苗類型

  • 概述
  • 2022 年及 2030 年魚疫苗市場收入佔有率(以疫苗類型)(%)
  • 去活化疫苗
  • 減毒活疫苗
  • 亞單位疫苗
  • 重組載體疫苗
  • 其他

第 7 章:亞太魚疫苗市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年及 2030 年魚疫苗市場收入佔有率(按應用分類)(%)
  • 細菌感染
  • 病毒感染
  • 寄生

第 8 章:亞太魚疫苗市場 - 收入和 2030 年預測 - 按給藥途徑

  • 概述
  • 2022 年及 2030 年魚疫苗市場收入佔有率(按給藥途徑)(%)
  • 注射疫苗
  • 浸沒疫苗
  • 口服疫苗

第 9 章:亞太魚疫苗市場 - 收入和 2030 年預測 - 按物種

  • 概述
  • 2022 年和 2030 年按物種分類的魚疫苗市場收入佔有率 (%)
  • 鮭魚
  • 鱒魚
  • 羅非魚
  • 其他

第 10 章:亞太魚疫苗市場 - 國家分析

  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區

第 11 章:魚疫苗市場 - 產業格局

  • 概述
  • 魚疫苗市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章:公司簡介

  • Zoetis Inc
  • Merck & Co Inc
  • HIPRA SA
  • Phibro Animal Health Corp
  • Vaxxinova International BV
  • Kyoto Biken Laboratories Inc
  • Elanco Animal Health Inc
  • Nisseiken Co Ltd
  • KBNP Inc
  • Choong Ang Vaccine Laboratory
  • Indian Immunologicals Ltd

第 13 章:附錄

Product Code: BMIRE00029704

The Asia Pacific fish vaccines market was valued at US$ 46.87 million in 2022 and is expected to reach US$ 94.15 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Development of Novel Fish Vaccine Fuels the Asia Pacific Fish Vaccine Market

Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.

Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.

Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.

Asia Pacific Fish Vaccines Market Overview

The Asia Pacific fish vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising aquaculture sector in the region and favorable government initiatives. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the fish vaccines market in the region. Commercial aquaculture production in Japan has developed dramatically since the end of the 2nd World War and occupies an important place in the fisheries sector. More than 60 species are included in the aquaculture section of the annual fisheries statistics. Of these, the main species are Nori, yesso scallop, oyster, Japanese amberjack, red seabream, and sea mustard. However, domestic demand for seafood products will decline in the next decade, and the production of aquaculture will decline if it remains dependent on domestic demand. This decline in demand in Japan is because Japan's population is dropping, and their diets are shifting toward meat.

Asia Pacific Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fish Vaccines Market Segmentation

The Asia Pacific fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Asia Pacific fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Asia Pacific fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Asia Pacific fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Asia Pacific fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Asia Pacific fish vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific fish vaccines market share in 2022.

Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; INDIAN IMMUNOLOGICALS LTD; KBNP Inc.; Kyoto Biken Laboratories; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova International BV; and Zoetis Inc. are some of the leading companies operating in the Asia Pacific fish vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Asia Pacific Fish Vaccine Market

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Fish Vaccine Market - Key Industry Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Government Initiatives to Develop Aquaculture Industry
    • 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 4.2 Market Restraints
    • 4.2.1 Stringent Regulations for Approval of Vaccine
  • 4.3 Market Opportunities
    • 4.3.1 Development of Novel Fish Vaccine
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Fish Vaccine
  • 4.5 Impact Analysis:

5. Fish Vaccine Market - Asia Pacific Market Analysis

  • 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

  • 6.1 Overview
  • 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • 6.3 Inactivated Vaccines
    • 6.3.1 Overview
    • 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Live Attenuated Vaccines
    • 6.4.1 Overview
    • 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.5 Subunit Vaccines
    • 6.5.1 Overview
    • 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.6 Recombinant Vector Vaccine
    • 6.6.1 Overview
    • 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • 7.3 Bacterial Infection
    • 7.3.1 Overview
    • 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Viral Infection
    • 7.4.1 Overview
    • 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.5 Parasitic
    • 7.5.1 Overview
    • 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • 8.3 Injection vaccine
    • 8.3.1 Overview
    • 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.4 Immersion Vaccine
    • 8.4.1 Overview
    • 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 8.5 Oral Vaccine
    • 8.5.1 Overview
    • 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

  • 9.1 Overview
  • 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
  • 9.3 Salmon
    • 9.3.1 Overview
    • 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.4 Trout
    • 9.4.1 Overview
    • 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.5 Tilapia
    • 9.5.1 Overview
    • 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. Asia Pacific Fish Vaccine Market - Country Analysis

  • 10.1 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Fish Vaccine Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
        • 10.1.2.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
        • 10.1.2.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
        • 10.1.2.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
        • 10.1.2.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Fish Vaccine Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zoetis Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck & Co Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 HIPRA SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Phibro Animal Health Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Vaxxinova International BV
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Kyoto Biken Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Elanco Animal Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nisseiken Co Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 KBNP Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Choong Ang Vaccine Laboratory
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Indian Immunologicals Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Fish Vaccine Market Segmentation
  • Table 2. Worldwide Fish Production and Consumption in 2022
  • Table 3. Major Bacterial Diseases in Fish
  • Table 4. Major Viral Diseases in Fish
  • Table 5. Major Parasitic Diseases in Fish
  • Table 6. Atlantic Salmon Production 2020
  • Table 7. China Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 8. China Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 9. China Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 10. China Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 11. Japan Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 12. Japan Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 13. Japan Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 14. Japan Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 15. India Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 16. India Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 17. India Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 18. India Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 19. Australia Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 20. Australia Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 21. Australia Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 22. Australia Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 23. South Korea Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 24. South Korea Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 25. South Korea Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 26. South Korea Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 27. Rest of Asia Pacific Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 28. Rest of Asia Pacific Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 29. Rest of Asia Pacific Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 30. Rest of Asia Pacific Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
  • Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
  • Table 33. Glossary of Terms, Asia Pacific Fish Vaccine Market

List Of Figures

  • Figure 1. Asia Pacific Fish Vaccine Market Segmentation, By Country
  • Figure 2. Asia Pacific Fish Vaccine Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
  • Figure 5. Asia Pacific Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
  • Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 11. Asia Pacific Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 15. Asia Pacific Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
  • Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
  • Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 24. Asia Pacific Fish Vaccine Market, by Key Country - Revenue, 2022 (US$ Thousand)
  • Figure 25. Asia Pacific Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
  • Figure 26. China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 27. Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 28. India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 29. Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 30. South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 31. Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
  • Figure 32. Growth Strategies in Fish Vaccine Market